Last 12 months
Inside the activity.
0 purchase rows · 240 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 200 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 31 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2021 Filed Oct 29, 2021 18:27 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 102,836 | $252.55 | $25,971,231.80 |
DisclosureSEC source: 0001209191-21-062041 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,124,405 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.00 to $252.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4) and (5) to this Form 4. Read SEC document |
| October 28, 2021 Filed Feb 3, 2022 21:33 UTC |
Ricks David ADirector · President & CEO
|
GiftCommon Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-22-000018 · wf-form5_164392396285190.xml · nonDerivative · entry 2 Ricks David A · CIK 0001538604 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,744 Read SEC document |
| October 27, 2021 Filed Oct 28, 2021 17:13 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 21,369 | $252.33 | $5,391,997.03 |
DisclosureSEC source: 0001209191-21-061867 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,227,241 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.00 to $252.945, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 20:06 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 8 | $238.98 | $1,911.84 |
DisclosureSEC source: 0000059478-21-000205 · wf-form4_163476039522394.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,349 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 20:09 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 40 | $238.98 | $9,559.20 |
DisclosureSEC source: 0000059478-21-000207 · wf-form4_163476055198409.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| October 18, 2021 Filed Oct 20, 2021 20:13 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 46 | $238.98 | $10,993.08 |
DisclosureSEC source: 0000059478-21-000209 · wf-form4_163476080396694.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,159 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 22:03 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 9 | $231.64 | $2,084.76 |
DisclosureSEC source: 0000059478-21-000200 · wf-form4_163234816959897.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,341 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 22:04 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0000059478-21-000201 · wf-form4_163234827123675.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 314 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 22:07 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 47 | $231.64 | $10,887.08 |
DisclosureSEC source: 0000059478-21-000202 · wf-form4_163234842761955.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,113 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 15:35 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,430 | $274.31 | $4,232,603.30 |
DisclosureSEC source: 0001209191-21-052465 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,248,610 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.00 to $274.68, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 17, 2021 Filed Aug 18, 2021 17:20 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,060 | $274.08 | $838,697.96 |
DisclosureSEC source: 0001209191-21-052155 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,264,040 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.00 to $274.355, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:06 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 7 | $269.94 | $1,889.58 |
DisclosureSEC source: 0000059478-21-000185 · wf-form4_162923434330772.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,281 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:08 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 36 | $269.94 | $9,717.84 |
DisclosureSEC source: 0000059478-21-000186 · wf-form4_162923448789367.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 16, 2021 Filed Aug 17, 2021 21:11 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 40 | $269.94 | $10,797.60 |
DisclosureSEC source: 0000059478-21-000187 · wf-form4_162923463359691.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,889 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,300 | $272.18 | $353,830.10 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,267,100 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $271.78 to $272.76, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,111 | $271.26 | $1,657,651.53 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,268,400 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $270.75 to $271.725, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 8,323 | $270.07 | $2,247,784.29 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,274,511 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.70 to $270.68, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 6,175 | $269.08 | $1,661,550.48 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,282,834 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.66 to $269.65, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 9,790 | $268.14 | $2,625,129.76 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,289,009 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.645 to $268.64, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 41,509 | $266.87 | $11,077,672.87 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,298,799 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.63 to $267.56, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 27,187 | $266.44 | $7,243,595.53 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,340,308 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.63 to $266.625, inclusive. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 19:48 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,316 | $264.81 | $1,142,919.96 |
DisclosureSEC source: 0001209191-21-050573 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,367,495 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.50 to $265.34, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), and (8) to this Form 4. Read SEC document |
| August 06, 2021 Filed Aug 9, 2021 16:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 7,597 | $264.05 | $2,005,965.06 |
DisclosureSEC source: 0001209191-21-050316 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,371,811 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.00 to $264.17, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 16:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,644 | $265.23 | $1,231,709.54 |
DisclosureSEC source: 0001209191-21-050110 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,379,408 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.00 to $265.52, inclusive. Read SEC document |
| August 05, 2021 Filed Aug 6, 2021 16:57 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 128,048 | $264.23 | $33,833,610.85 |
DisclosureSEC source: 0001209191-21-050110 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,384,052 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.00 to $264.99, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 300 | $269.87 | $80,960.70 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 10 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,512,100 F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $269.2683 to $270.25, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 679 | $268.54 | $182,340.70 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 9 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,512,400 F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $268.1603 to $269.0285, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,085 | $267.76 | $290,522.86 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 8 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,513,079 F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $267.1545 to $268.1217, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,409 | $266.70 | $642,468.26 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 7 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,514,164 F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.147 to $267.1199, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,430 | $265.52 | $645,213.60 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 6 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,516,573 F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.0931 to $266.0919, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,410 | $264.53 | $637,505.25 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 5 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,519,003 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.0783 to $265.0472, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,210 | $263.48 | $582,290.80 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 4 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,521,413 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $263.06 to $264.0296, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 1,214 | $262.74 | $318,967.57 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,523,623 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $262.06 to $263.05, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 352 | $261.59 | $92,079.33 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,524,837 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $261.0537 to $261.8898, inclusive. Read SEC document |
| August 04, 2021 Filed Aug 5, 2021 19:52 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 369 | $260.19 | $96,010.48 |
DisclosureSEC source: 0001209191-21-049909 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,525,189 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.7119 to $260.59, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), (3), (4), (5), (6), (7), (8), (9), and (10) to this Form 4. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 2,079 | $258.06 | $536,502.58 |
DisclosureSEC source: 0001209191-21-049587 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,525,558 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $258.04 to $258.29, inclusive. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,075 | $257.68 | $2,596,136.08 |
DisclosureSEC source: 0001209191-21-049587 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,527,637 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.0099 to $258.00, inclusive. Read SEC document |
| August 03, 2021 Filed Aug 4, 2021 19:15 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 224,388 | $256.03 | $57,449,835.25 |
DisclosureSEC source: 0001209191-21-049587 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,537,712 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $256.00 to $256.73, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2), and (3) to this Form 4. Read SEC document |
| July 21, 2021 Filed Jul 22, 2021 14:47 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 86,111 | $237.00 | $20,408,307.00 |
DisclosureSEC source: 0001209191-21-047671 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,762,100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.01, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 20, 2021 Filed Jul 21, 2021 15:12 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 15,610 | $237.06 | $3,700,428.55 |
DisclosureSEC source: 0001209191-21-047547 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,848,211 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.75, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 20:10 UTC |
JOHNSON KIMBERLY HDirector
|
GrantCommon Stock | 41 | $234.14 | $9,599.74 |
DisclosureSEC source: 0000059478-21-000157 · wf-form4_162689819259778.xml · nonDerivative · entry 1 JOHNSON KIMBERLY H · CIK 0001658089 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 20:18 UTC |
TAI JACKSON PDirector
|
GrantCommon Stock | 8 | $234.14 | $1,873.12 |
DisclosureSEC source: 0000059478-21-000159 · wf-form4_162689867189510.xml · nonDerivative · entry 1 TAI JACKSON P · CIK 0001173275 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,274 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 19, 2021 Filed Jul 21, 2021 20:23 UTC |
Alvarez RalphDirector
|
GrantCommon Stock | 47 | $234.14 | $11,004.58 |
DisclosureSEC source: 0000059478-21-000161 · wf-form4_162689898615045.xml · nonDerivative · entry 1 Alvarez Ralph · CIK 0001310215 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,849 F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service. Read SEC document |
| July 14, 2021 Filed Jul 15, 2021 18:03 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 10,780 | $237.02 | $2,555,118.72 |
DisclosureSEC source: 0001209191-21-046740 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,863,821 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.14, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 12, 2021 Filed Jul 13, 2021 19:08 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 3,238 | $237.09 | $767,694.18 |
DisclosureSEC source: 0001209191-21-046471 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,874,601 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.325, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 09, 2021 Filed Jul 12, 2021 16:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 12,248 | $238.07 | $2,915,905.86 |
DisclosureSEC source: 0001209191-21-046268 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,877,839 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $238.00 to $238.33, inclusive. Read SEC document |
| July 09, 2021 Filed Jul 12, 2021 16:58 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 97,013 | $237.30 | $23,021,184.90 |
DisclosureSEC source: 0001209191-21-046268 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,890,087 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $237.00 to $237.995, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. Read SEC document |
| July 06, 2021 Filed Jul 7, 2021 13:17 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 210,000 | $235.09 | $49,369,047.00 |
DisclosureSEC source: 0001209191-21-045737 · doc4.xml · nonDerivative · entry 1 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,987,100 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $235.00 to $235.55, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 17:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 4,300 | $234.13 | $1,006,737.50 |
DisclosureSEC source: 0001209191-21-045315 · doc4.xml · nonDerivative · entry 3 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,197,100 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $234.105 to $234.22, inclusive. Read SEC document |
| July 02, 2021 Filed Jul 6, 2021 17:05 UTC |
LILLY ENDOWMENT INC10% owner
|
SaleCommon Stock | 50,075 | $233.58 | $11,696,268.13 |
DisclosureSEC source: 0001209191-21-045315 · doc4.xml · nonDerivative · entry 2 LILLY ENDOWMENT INC · CIK 0000316011 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,201,400 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $233.09 to $234.06, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.